Healthy Living

Canadians Now Have More Options to Treat Hodgkin Lymphoma

Things to consider before using ADCETRIS

Patients with moderate or severe hepatic impairment or severe renal impairment should avoid use.

Women should avoid pregnancy during ADCETRIS treatment and avoid getting pregnant for at least six months following the last dose of ADCETRIS.

Women should avoid breastfeeding while under ADCETRIS treatment.

For men who have female sexual partners, use effective contraception during ADCETRIS treatment and for at least six months following the last dose of ADCETRIS.

For additional Important Safety Information, see the full Prescribing Information for ADCETRIS at www.seattlegenetics.com or www.ADCETRIS.com.